Navigation Links
HBO, Gladstone Institute of Neurological Disease, UC Davis Alzheimer's Disease Center, UCSF Memory & Aging Center and The Alzheimer's Association, No. Cal. Present an Advance Screening of THE ALZHEIMER'S PROJECT: 'Momentum In Science'
Date:4/7/2009

Panel Discussion To Follow With Leading Alzheimer's Experts Featured In Film

SAN FRANCISCO, April 7 /PRNewswire/ --

    WHAT:       HBO, Gladstone Institute Of Neurological Disease, UC Davis
                Alzheimer's Disease Center, UCSF Memory & Aging Center and
                The Alzheimer's Association, No. Cal. present an advance
                screening of the "Momentum In Science" documentary film from
                HBO's THE ALZHEIMER'S PROJECT free to the public on
                Wednesday, April 22.
                Immediately following the screening, a distinguished panel
                of Alzheimer's experts will hold a discussion moderated by
                former KVIE television reporter, Pat McConahay.
                A co-presentation with the National Institute on Aging,
                this multi-platform series takes a close look at
                groundbreaking discoveries made by the country's leading
                scientists, as well as the effects of this debilitating and
                fatal disease on those with Alzheimer's and their families. 
                California First Lady Maria Shriver serves as Executive
                Producer of the series.
                THE ALZHEIMER'S PROJECT debuts May 10. For more information,
                go to: HBO.com/Alzheimers.

    WHEN:       WEDNESDAY, APRIL 22, 2009
                6:00 P.M. - Doors Open              7:00 P.M. - Screening
                8:00 P.M. - Panel Discussion

    WHERE:      NOB HILL MASONIC CENTER, 1111 California Street, San Francisco

    PANEL:      Charles DeCarli, MD: Professor of Neurology; Director, UC
                Davis Alzheimer's Disease Center
                Lennart Mucke, MD: Director & Senior Investigator, Gladstone
                Institute of Neurological Disease
                Dale Schenk, PhD: Executive Vice President & Chief Science
                Officer, Elan Pharmaceuticals
                Moderator: Pat McConahay, Freelance Reporter

    ADD:        John Hoffman, Producer, ALZHEIMER'S

    INFO:       The public is invited to this free event; RSVP at 415.765.7793
                or online:https://homeboxoffice.com/rsvp/alzheimersSF


'/>"/>
SOURCE HBO
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Gladstone scientists identify role of fatty acids in Alzheimers disease
2. Gladstone scientists identify single microRNA that controls blood vessel development
3. Laser Spine Institute Helps Professionals Take Back Their Lives from Debilitating Back Pain
4. Komen Detroit and the Karmanos Cancer Institute Applaud Introduction of Bipartisan Cancer Alert Act
5. Tomato Products Wellness Council Joins Harvard Medical School and the Culinary Institute of America to Take Part in Healthy Kitchen, Healthy Lives April 2-5, 2009
6. Waters Corporation Announces the Purchase of UPLC/MS Systems by the National Cancer Institute for Advanced Metabolomics Research
7. ACC presents lifetime achievement award to Cedars-Sinai Heart Institutes James Forrester, M.D.
8. ALS Therapy Development Institute: More Burrito!
9. Dr. Rudy Kachmann, Neurosurgeon, Author, Lecturer & Founder of Kachmann Mind Body Institute Selects TransMedia Group as Agency of Record
10. Gary and Mary West Foundation Commits $45 Million to Create Wireless Health Institute
11. 2 NYU scientists named Howard Hughes Medical Institutes Early Career Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... director. Mr. Still was selected through a careful months-long search by the RBMA Board ... to our members, has been a part of building the RBMA since 1992,” said ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... release of two biometric time and attendance tracking products: the new NCheck Cloud ... NCheck Cloud Bio Attendance uses biometric face recognition to enable users to check ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Executives, Staff & Clients ... to for the Toys for Tots Literacy Campaign at their Semi-Annual Graduation and Fundraiser ... $70 billion, the U.S. ranks at number 14 internationally in literacy. Statistically, a direct ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon ... this procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Silicon Valley Hair ... to announce a new blog post about women’s hair loss. Although hair transplant procedures ... loss as they age. Menopause or genetics can be two reasons a woman may ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... REDWOOD CITY, Calif. , March 28, 2017 ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that the European Medicines Agency ... (sufentanil sublingual tablet, 30 mcg) Marketing Authorisation Application ... review of the MAA is underway. The MAA ...
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
(Date:3/28/2017)... , March 28, 2017 ... to reach USD 8.0 billion by 2025, according to ... increasing incidence of infectious diseases and cancer is expected ... in disease diagnosis over the coming years. In addition, ... of autologous and allogenic stem cell therapy, due to ...
Breaking Medicine Technology: